Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Seth Toback, M.D.
Novavax, Inc.
Disclosure(s): Novavax, Inc.: employee, Stocks/Bonds (Public Company)
Poster(s):
(P-1657) Difference in reactogenicity events between mRNA and Protein-subunit Vaccines: Results from the Booster Epidemiological Evaluation of Health, Illness, and Vaccine Efficacy (BEEHIVE) Study, a U.S. randomized trial of 2023-2024 COVID-19 vaccines (XBB.1.5)
Wednesday, October 22, 2025
12:15 PM - 1:30 PM
US ET
